lobbying_activities: 507610

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
507610	dd91cb70-f017-4ab6-ba5c-0cbe16a82541	MM	CEPHALON, INC.	8761	CEPHALON INC	2007	mid_year	CPT	H.R. 2795, Patent Reform Act. Provisions related to pharmaceutical patents. H.R. 5418, Establishing a pilot program for patent cases; S. 3582, Preserve Access to Affordable Generics Act; H.R. 1432, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. H.R. 2642, Military Construction and Veteran's Affairs Appropriations Act, 2008.	Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)		531219	0	0	2007-07-31T10:18:41-04:00